2-oxo-hept-3-ene-1,7-dioate hydratase activity
phenotype
Molecular Function
14
0.300
strong
1.000
1
2018
2018
Adenocarcinoma
group
Neoplasms
Neoplastic Process
2235
168
0.010
None
1.000
1
2020
2020
Adenocarcinoma in Situ
phenotype
Pathological Conditions, Signs and Symptoms; Neoplasms
Neoplastic Process
55
0.010
None
< 0.001
1
2020
2020
Adenocarcinoma, Endometrioid
disease
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
Neoplastic Process
130
4
0.010
None
< 0.001
1
2019
2019
Adenoma
group
Neoplasms
Neoplastic Process
1183
103
0.010
None
1.000
1
2014
2014
Adenoma of large intestine
disease
Digestive System Diseases; Neoplasms
Neoplastic Process
452
213
0.010
None
1.000
1
2008
2008
Adult Cholangiocarcinoma
disease
Neoplasms
Neoplastic Process
13
0.200
None
1.000
1
2010
2010
Adult Germ Cell Tumor
disease
Neoplasms
Neoplastic Process
62
0.010
None
1.000
1
2020
2020
Adult Glioblastoma
disease
Neoplasms
Neoplastic Process
2528
98
0.010
None
1.000
1
2013
2013
Adult Oligodendroglioma
disease
Neoplasms
Neoplastic Process
154
19
0.010
None
1.000
1
2014
2014
Anaplasia
disease
Pathological Conditions, Signs and Symptoms; Neoplasms
Neoplastic Process
538
7
0.020
None
1.000
2
2017
2017
Anaplastic Oligodendroglioma
disease
Neoplasms
Neoplastic Process
66
7
0.010
None
1.000
1
2014
2014
Androgen-Insensitivity Syndrome
disease
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases
Disease or Syndrome
247
176
0.010
None
< 0.001
1
2020
2020
Arteriovenous hemangioma
disease
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Cardiovascular Diseases
Neoplastic Process
76
14
0.010
None
1.000
1
2016
2016
Associated Pulmonary Arterial Hypertension
disease
Respiratory Tract Diseases
Disease or Syndrome
22
4
0.020
None
1.000
2
2018
2019
Asthma
disease
Respiratory Tract Diseases; Immune System Diseases
Disease or Syndrome
2096
1536
0.010
None
1.000
1
2019
2019
Benign Neoplasm
group
Neoplasms
Neoplastic Process
371
7
0.010
None
1.000
1
2009
2009
Biliary Atresia
disease
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Digestive System Diseases
Congenital Abnormality
184
32
0.200
None
1.000
2
2013
2017
Breast Carcinoma
disease
Neoplasms; Skin and Connective Tissue Diseases
Neoplastic Process
6776
2793
0.100
None
1.000
11
2010
2018
×
CUI:
C1968949
Disease:
Cakut
Cakut
disease
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
Disease or Syndrome
72
8
0.010
None
1.000
1
2012
2012
Carcinogenesis
phenotype
Pathological Conditions, Signs and Symptoms; Neoplasms
Neoplastic Process
6243
355
0.060
None
1.000
6
2008
2015
Carcinoma breast stage IV
disease
Neoplastic Process
573
14
0.010
None
1.000
1
2017
2017
Carcinoma of lung
disease
Neoplasms; Respiratory Tract Diseases
Neoplastic Process
4081
1204
0.010
None
1.000
1
2012
2012
Carcinoma, Endometrioid
disease
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
Neoplastic Process
223
12
0.010
None
< 0.001
1
2019
2019
Carcinoma, Ovarian Epithelial
disease
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
Neoplastic Process
2841
327
0.010
None
1.000
1
2015
2015